Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical Practice

Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol... Adv Ther (2017) 34:2648–2660 DOI 10.1007/s12325-017-0641-5 ORIGINAL RESEARCH Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical Practice . . . Michał Pirozyn _ ´ ski Piotr Hantulik Agnieszka Almgren-Rachtan Jerzy Chudek Received: October 2, 2017 / Published online: November 8, 2017 The Author(s) 2017. This article is an open access publication (age 49.8 ± 17.9 years) with asthma treated with ABSTRACT Bufomix Easyhaler for at least 14 days before enrolment. Asthma control was assessed during Introduction: The effectiveness of single-in- three subsequent visits with 8–12-week intervals haler budesonide/formoterol fumarate combi- on the basis of the Asthma Control Test (ACT). nation therapy for asthma has been previously Adherence was assessed with the Medication shown for the original product. The aim of this Adherence Questionnaire. In addition, patient nonrandomized, open-label, postauthorization satisfaction with Bufomix Easyhaler was efficacy study (PAES) real-life clinical assessment scored, and adverse drug reactions were was to evaluate the clinical effectiveness of a recorded. second product (Bufomix Easyhaler ) in the Results: The percentage of patients with daily clinical practice of asthma therapy. well-controlled asthma or total control of Methods: This multicenter PAES was conducted asthma (ACT http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Therapy Springer Journals

Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical Practice

Loading next page...
 
/lp/springer_journal/evaluation-of-the-efficiency-of-single-inhaler-combination-therapy-vca90PlLil
Publisher
Springer Healthcare
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Oncology; Cardiology; Rheumatology; Endocrinology; Pharmacology/Toxicology
ISSN
0741-238X
eISSN
1865-8652
D.O.I.
10.1007/s12325-017-0641-5
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial